Please ensure Javascript is enabled for purposes of website accessibility

Could Worse Coronavirus Variants Than Delta Be on the Way?

By Keith Speights and Brian Orelli, PhD – Sep 5, 2021 at 5:55AM

Key Points

  • There are already some coronavirus variants that have been identified after the delta variant.
  • It remains to be seen if more serious variants than delta will become prevalent, but it's a possibility.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately, it's possible.

Dealing with the delta variant has proven to be more difficult than hoped. It's more contagious than earlier coronavirus strains. The efficacy of COVID-19 vaccines appears to be lower against delta. But could things get even worse? In this Motley Fool Live video recorded on Aug. 25, Motley Fool contributors Keith Speights and Brian Orelli address a viewer's question about new variants beyond delta that could potentially be on the way.

10 stocks we like better than Moderna Inc.
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

They just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of August 9, 2021

 

Keith Speights: Jim R. asks, "Is there any new iteration of the COVID-19 No yet." I'm assuming Jim is referring to new variants beyond the delta variant, maybe. Do you think maybe that's just the question here?

Brian Orelli: Probably. I think we're beyond delta now, but I don't think the one beyond delta is worse than delta, so I think that's where we're at right now. I'm 99% sure I read that we were beyond delta. They're going by the Greek alphabet, I think so.

Speights: Yeah. There is a lambda variant you don't hear much about. I did see something interesting that, I think this was Moderna's (MRNA 3.15%) president in Moderna's Q2 call, stated that Moderna is concerned about a combination of some of the worst mutations between several of the variants floating around right now.

In fact, he said it could be scary. We can't rule out the possibility that more variants will emerge that are even more contagious than delta. That just remains to be seen.

Orelli: Yeah. I think the biggest issue is going to be variants of delta. I think those will still go by the Greek alphabet. I don't think they'll spin off delta to go someplace else. But I think the variants of delta are probably the most scary because it's going to take delta and then go even worse.

The reason why they get worse, in theory, is because there's a selection pressure. If there's a mutation as the virus is replicating in one person, if there is a mutation that makes it more virulent, which means it can replicate faster and infect faster, produce more virus faster, than that will be selected for because that one will be able to replicate faster.

Therefore, when it gets to next host, it'll be replicating faster than the other viruses that get transferred as well, then eventually it gets selected for because the rate of infection is improved and so then that becomes the predominant virus in that area.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Moderna Inc. The Motley Fool has a disclosure policy.

Stocks Mentioned

Moderna Stock Quote
Moderna
MRNA
$179.00 (3.15%) $5.46

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.